AcelRx Pharmaceuticals Stock Price (Quote) NASDAQ:ACRX
$2.24 ( -4.27% ) Friday, 2nd Dec 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.76 | $2.98 | Friday, 2nd Dec 2022 ACRX stock ended at $2.24. This is 4.27% less than the trading day before Thursday, 1st Dec 2022. During the day the stock fluctuated 4.58% from a day low at $2.20 to a day high of $2.30. |
| 90 days | $0.195 | $4.14 | |
| 52 weeks | $0.160 | $4.14 |
Historical AcelRx Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2022-12-02 | $2.22 | $2.30 | $2.20 | $2.24 | 52 681 |
| 2022-12-01 | $2.34 | $2.44 | $2.15 | $2.34 | 262 012 |
| 2022-11-30 | $2.39 | $2.40 | $2.25 | $2.32 | 97 773 |
| 2022-11-29 | $2.37 | $2.44 | $2.34 | $2.40 | 32 579 |
| 2022-11-28 | $2.35 | $2.46 | $2.33 | $2.38 | 61 317 |
| 2022-11-25 | $2.28 | $2.39 | $2.21 | $2.35 | 34 587 |
| 2022-11-23 | $2.22 | $2.33 | $2.16 | $2.29 | 53 984 |
| 2022-11-22 | $2.27 | $2.39 | $2.14 | $2.34 | 134 725 |
| 2022-11-21 | $2.33 | $2.51 | $2.18 | $2.26 | 278 107 |
| 2022-11-18 | $2.41 | $2.48 | $2.25 | $2.34 | 327 715 |
| 2022-11-17 | $2.38 | $2.49 | $2.25 | $2.42 | 157 952 |
| 2022-11-16 | $2.58 | $2.60 | $2.32 | $2.46 | 120 994 |
| 2022-11-15 | $2.31 | $2.98 | $2.26 | $2.54 | 283 005 |
| 2022-11-14 | $2.17 | $2.37 | $2.06 | $2.28 | 226 393 |
| 2022-11-11 | $2.07 | $2.21 | $2.02 | $2.07 | 140 635 |
| 2022-11-10 | $1.79 | $2.02 | $1.78 | $2.02 | 102 977 |
| 2022-11-09 | $1.97 | $2.03 | $1.76 | $1.79 | 167 051 |
| 2022-11-08 | $2.16 | $2.20 | $1.94 | $1.97 | 129 609 |
| 2022-11-07 | $1.97 | $2.34 | $1.91 | $2.14 | 186 662 |
| 2022-11-04 | $2.24 | $2.25 | $1.94 | $1.94 | 167 565 |
| 2022-11-03 | $2.21 | $2.30 | $2.20 | $2.23 | 58 410 |
| 2022-11-02 | $2.42 | $2.48 | $2.23 | $2.27 | 126 922 |
| 2022-11-01 | $2.64 | $2.66 | $2.40 | $2.47 | 123 455 |
| 2022-10-31 | $2.75 | $2.85 | $2.50 | $2.64 | 207 131 |
| 2022-10-28 | $3.23 | $3.37 | $2.60 | $2.77 | 381 870 |
| 2022-10-27 | $3.65 | $3.81 | $3.22 | $3.23 | 330 092 |
| 2022-10-26 | $3.86 | $4.14 | $3.36 | $3.69 | 412 473 |
| 2022-10-25 | $0.227 | $0.230 | $0.195 | $0.212 | 1 699 873 |
| 2022-10-24 | $0.202 | $0.228 | $0.202 | $0.213 | 692 599 |
| 2022-10-21 | $0.201 | $0.219 | $0.195 | $0.201 | 706 184 |
| 2022-10-20 | $0.202 | $0.217 | $0.202 | $0.202 | 448 770 |
| 2022-10-19 | $0.227 | $0.237 | $0.205 | $0.215 | 676 897 |
| 2022-10-18 | $0.220 | $0.239 | $0.216 | $0.230 | 541 501 |
| 2022-10-17 | $0.210 | $0.220 | $0.210 | $0.214 | 350 675 |
| 2022-10-14 | $0.220 | $0.220 | $0.210 | $0.216 | 357 719 |
| 2022-10-13 | $0.200 | $0.220 | $0.197 | $0.217 | 981 534 |
| 2022-10-12 | $0.202 | $0.210 | $0.197 | $0.203 | 718 776 |
| 2022-10-11 | $0.195 | $0.210 | $0.195 | $0.201 | 405 527 |
| 2022-10-10 | $0.200 | $0.206 | $0.198 | $0.202 | 388 255 |
| 2022-10-07 | $0.212 | $0.220 | $0.199 | $0.201 | 652 144 |
| 2022-10-06 | $0.218 | $0.226 | $0.201 | $0.209 | 618 733 |
| 2022-10-05 | $0.213 | $0.229 | $0.210 | $0.221 | 292 505 |
| 2022-10-04 | $0.240 | $0.243 | $0.217 | $0.220 | 575 430 |
| 2022-10-03 | $0.200 | $0.230 | $0.198 | $0.220 | 1 195 927 |
| 2022-09-30 | $0.211 | $0.230 | $0.208 | $0.209 | 597 023 |
| 2022-09-29 | $0.221 | $0.230 | $0.210 | $0.212 | 3 872 637 |
| 2022-09-28 | $0.214 | $0.223 | $0.210 | $0.217 | 327 339 |
| 2022-09-27 | $0.210 | $0.225 | $0.208 | $0.214 | 700 818 |
| 2022-09-26 | $0.229 | $0.230 | $0.200 | $0.207 | 1 202 163 |
| 2022-09-23 | $0.230 | $0.240 | $0.220 | $0.240 | 905 610 |
About AcelRx Pharmaceuticals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai... ACRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
